Status:
COMPLETED
Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells
Lead Sponsor:
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Collaborating Sponsors:
Belarusian State Medical University
Conditions:
COVID
Covid-19
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
Treatment of patients with Covid-19 associated pneumonia using intravenous injection of allogenic pooled olfactory mucosa-derived mesenchymal stem cells
Detailed Description
During the implementation of the project, it is planned to develop a method for the treatment of severe covid-19 associated interstitial pneumonia using allogeneic mesenchymal stem cells. The positive...
Eligibility Criteria
Inclusion
- PCR-confirmed Covid-19 pneumonia
- respiratory failure
Exclusion
- diagnosed cancer
Key Trial Info
Start Date :
May 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04382547
Start Date
May 11 2020
End Date
June 30 2021
Last Update
August 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Minsk, Belarus, 220072